Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical compositions containing them and process for preparing same

Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical compositions containing them and process for preparing same

Gen. Pharmac. Vol. 23, No. 5, pp. i-vi, 1992 Pergamon Press Ltd. Printed in Great Britain NEW PATENTS This section contains abstracts and, where app...

71KB Sizes 0 Downloads 92 Views

Gen. Pharmac. Vol. 23, No. 5, pp. i-vi, 1992

Pergamon Press Ltd. Printed in Great Britain

NEW PATENTS This section contains abstracts and, where appropriate, illustrations of recently issued United States patents and published patent application filed from over 30 countries under the Patent Cooperation Treaty. This information was obtained from recent additions to the PATSEARCH® online database in accordance with interest profiles developed by the Editors. Further information about online patent searchingcan be obtained from Research on Demand, Inc., 2421 Fourth Street, Ste. C., Berkeley, CA 94710, U.S.A. [Tel. 510-841 1145; Fax 510-841 6311].

5096898 BILE ACID UNSATURATED DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Roberto Pellicciari, Aldo Roda, Milan, Italy assigned to Giuliani S p A Bile acid derivatives of formula I See Patent for Chemical Structure (I) wherein: R is hydrogen or hydroxy; X is a carboxy or a SO3H group, have valuable pharmacologic properties.

ceutical compositions containing them and a process for their preparation. In the formula (I) See Patent for Chemical Structure (I) Ar stands for an optionally mono- or polysubstituted aryl or heteroaryl group; R1 means a carbonyl or (C2-6alkenyl)carbonyl group; R2 stands for hydrogen C1-6alkyl, phenyl or phenyl (C14alkyl) group; R3 means hydrogen or (C16alkoxy)carbonyl group; R4 and R5 stand, independently from each other, for hydrogen or C1-6alkyl group; R6 ogen, C1-6alkyl group or halophenyl group; m is 0 or 1; and n is 1 or 2, with the proviso that R2 means hydrogen when m is 0. The compounds of formula (I) show a significant cerebral antihypoxic action and thus, they can be used for the treatment of diseases caused by hypoxic brain damages such as e.g. the senile dementia, Alzheimer's disease or disturbances of the cognitive function.

5096902 HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN AND SULFUR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME Karoly Nador, Pal Scheiber, nee Szelecsenyi Erzsebet Andrasi, Bela Molnar, Laszlo Kiss Bela Szporny, Ego Karpati, Eva Palosi, GrooDora, Istvan Laszlovszky, Zsolt Szombathelyi, Ada Sarkadi, AnikoBodoMihaly Gere, Katalin Csomor, Judit Laszy, Zsolt Szentirmay, Budapest, Hungary assigned to Richter Gedeon Vegyeszeti Gyar Rt The invention relates to novel nitrogen- and sulfur-containing heteroeyclic compounds of the formula (I), acid addition salts thereof, pharma-

5096920 1,2-DITHIOL-3 THION-S-OXIDE C O M P O U N D S AND PHARMACEUTICAL COMPOSITIONS Dominiqu Biard, Marie-Odile Christen, Patrick Dansette, Daniel Jasserand, Daniel Mansuy, Amor Sassi, Trivier sur Moignans, France assigned to Kali-Chemie Pharma GmbH The use of 5-phenyl-3H-1,2-dithiol 3-thion-Soxides which are optionally substituted in the phenyl ring as active substances in hepatoprotective medicaments and new 5-phenyl-3H1,2-dithiol 3-thion-S-oxides which are substituted in the phenyl ring are described.